Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 1-10 of 86

Page
per page
  1. 1-Naphthyl 3,5-dinitrobenzoate
    C3794 1-Naphthyl 3,5-dinitrobenzoate
    Summary: dual 5-lipoxygenase and microsomal prostaglandin E synthase-1 inhibitor
      ≤0.1 mg/mL
  2. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
    Target: Ferroptosis
    Summary: Ferroptosis inhibitor, erastin-induced
      ≥149 mg/mL
  3. Liproxstatin-1
    B4987 Liproxstatin-1
     1 Citation
    Summary: A potent ferroptosis inhibitor
      insoluble in H2O; ≥10.5 mg/mL
  4. Qc 1
    B5799 Qc 1
    Summary: threonine dehydrogenase (TDH) inhibitor
      <22.77 mg/mL
  5. IDO inhibitor 1
    A3483 IDO inhibitor 1
    Summary: Indoleamine-2,3-dioxygenase inhibitor
      insoluble in H2O; ≥19.35 mg/mL
  6. IDO-IN-1
    C3211 IDO-IN-1
    Summary: indoleamine-2,3-dioxygenase (IDO) inhibitor
      ≥29.1 mg/mL
  7. PluriSIn #1 (NSC 14613)
    A4351 PluriSIn #1 (NSC 14613)
    Target: Stearoyl-CoA 9-desaturase (SCD-1)
    Summary: SCD1 inhibitor
  8. DGAT-1 inhibitor
    A3363 DGAT-1 inhibitor
    Summary: Diacylglycerol acyltransferase (DGAT1) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥39.4 mg/mL
  9. Alda 1
    B5508 Alda 1
    Target: Aldehyde Dehydrogenases
    Summary: ALDH2 activator
      insoluble in H2O; ≥15.15 mg/mL
  10. Liproxstatin-1 HCl
    B8221 Liproxstatin-1 HCl
    Summary: A potent ferroptosis inhibitor
      insoluble in EtOH; ≥18.85 mg/mL

Items 1-10 of 86

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
Clear All
Shopping Options
Category
  1. PPAR 6item
  2. 5-Lipoxygenase 3item
  3. Adenosine Deaminase 2item
  4. Aminopeptidase 1 item
  5. Carbonic Anhydrase 1 item
  6. Cholesterol absorption 1 item
  7. CPT1 1 item
  8. CYP3A/CYP450 3item
  9. Dehydrogenase 7item
  10. DHFR 2item
  11. DGAT 4item
  12. Dopamine β-hydroxylase 1 item
  13. FAAH 1 item
  14. Ferroptosis 3item
  15. Folate Analogue 1 item
  16. HMG-CoA Reductase 3item
  17. HSP 5item
  18. IDO 4item
  19. KRAS-PDEδ 2item
  20. Lipid Metabolism 2item
  21. MAO 1 item
  22. Neuronal Metabolism 1 item
  23. P450 5item
  24. PDE 4item
  25. Phospholipase 4item
  26. Procollagen C Proteinase 1 item
  27. SCD 1 item
  28. SGLT 1 item
  29. TPH 2item
  30. Transferase 8item
  31. aldehyde dehydrogenase 1 item
  32. Amino acid metabolism 1 item
  33. Others 1 item
  34. Galactosidase 1 item
  35. Lipase inhibitor 1 item
Specificity
  1. Selective 19item
Reversibility
  1. Irreversible 1 item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Phosphodiesterases (PDEs) 2item
  3. Aminopeptidases 1 item
  4. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  5. HSP90 1 item
  6. Cytochrome P450 (CYP450) 1 item
  7. Ferroptosis 1 item
  8. HMG-CoA Reductases 1 item
  9. DGAT 2item
  10. Lactate Dehydrogenases (LDH) 1 item
  11. Fatty-acid-binding proteins (FABPs) 1 item
  12. Nampt 1 item
  13. Carbonic Anhydrases 1 item
  14. Aldehyde Dehydrogenases 1 item
  15. Tryptophan hydroxylases (TPH) 1 item
  16. PPAR 1 item
  17. Ftase 1 item
  18. HMGCR 1 item
  19. Tph 1 item
  20. Cholesterol absorption 1 item
Reported Experiments
  1. Animal Experiments 28item
  2. Cell Experiments 23item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Breast Cancer 4item
  3. Cancer 8item
  4. Epilepsy 1 item
  5. Glioma 1 item
  6. Hypercholesterolemia 2item
  7. Leukemia 1 item
  8. Lung Cancer 1 item
  9. Lymphoma 1 item
  10. Melanoma 2item
  11. Neuroblastoma 1 item
  12. Non-small Cell Lung Cancer 1 item
  13. Pancreatic Cancer 1 item
  14. Pancreatic Carcinoma 1 item
  15. Prostate Cancer 3item
  16. Psoriasis 1 item
  17. Type 2 Diabetes 1 item